Published in Obesity and Diabetes Week, March 29th, 2010
"In addition, other studies revealed that there is more to diabetes therapy than lowering blood glucose, which might under certain circumstances even harm patients. In the light that we now know that ''death'' is as important an end-point in diabetes as in other diseases, new tools - better than the oral glucose tolerance test - are required to identify the patients at risk, as are additional standards in individualized...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.